Share: Facebook Twitter LinkedIn
Activity Provided By:

CEimpact

Is Colchicine the 2020 Comeback Kid?

Access Activity

Overview / Abstract:

Colchicine has been used in medicine for > 2000 years and current established uses include treatment of gout, Familial Mediterranean Fever, and pericarditis, although it has been studied in a wide range of conditions including atrial fibrillation, cancer, and more recently prevention of ischemic events in patients with coronary heart disease. Despite lifestyle changes and significant advances in medicine and interventional cardiology, patients with coronary heart disease remain at high risk for cardiovascular events creating a continued focus on measures to mitigate risk. Will colchicine comeback to fame and help mitigate cardiovascular adverse events?

Expiration

Dec 09, 2023

Discipline(s)

Pharmacy CPE

Format

Online, Webinar / Webcast / Video

Cost

9.00

Credits / Hours

0.20

Accreditation

ACPE

Presenters / Authors / Faculty

Lindsay Davis, PharmD, BCPS, ASH-CHC, TTS, FAzPA
Associate Professor
Midwestern University College of Pharmacy - Glendale

Keywords / Search Terms

CEimpact CEI Impact CEI ce, cardiovascular disease, cardiology, journal club, pharmaceutical care, trial, clinical trial, journal, adverse drug reactions, come back

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map